Eurofins Scientific SEEigentümerstruktur
| Preis (2026-07-29) | 52W Hoch | 52W Tief |
| 68.64 EUR | 73,451 EUR | 54,218 EUR |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - EUR | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 172.783.324 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Eurofins Scientific SE
Mitarbeiter 65.000
Handelsplatz PA
Ticker Symbol ERF
IPO Datum -
Adresse 23 Val Fleuri, Luxembourg, Luxembourg, 1526
Webseite https://www.eurofins.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Gilles G. Martin Ph.D. | Chairman of the Board & CEO |
| 2 | Ms. Valerie Hanote | Executive Director |
| 3 | Mr. Laurent Lebras | Group Administration & CFO |
| 4 | Mr. David W. Bryant | Senior VP of Strategic Business Development North America |
| 5 | Mr. Gabriel Julia | Senior VP of Clinical Diagnostics Europe |
| 6 | Dr. Timothy S. Oostdyk | Executive VP of BioPharma, Genomics & Agrosciences Services North America |
| 7 | Mr. Joachim Reichelt | Senior Vice President of Food & Feed Testing Europe |
| 8 | Ms. Yvoine Remy | Senior Vice President of Environment Testing Europe |
| 9 | Mr. Francois Vigneau | Senior Vice President of Food & Feed Testing - Western Europe |
| 10 | Mr. Brian Williams | Executive VP of Environment Testing North America & Regional Multi Business Lines Leader Pacific |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.